Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke
- PMID: 26396522
- PMCID: PMC4577252
- DOI: 10.2147/NDT.S85698
Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke
Abstract
Background: There are no currently effective cognitive assessment tools for patients who have suffered stroke in the People's Republic of China. The Birmingham Cognitive Screen (BCoS) has been shown to be a promising tool for revealing patients' poststroke cognitive deficits in specific domains, which facilitates more individually designed rehabilitation in the long run. Hence we examined the reliability and validity of a Cantonese version BCoS in patients with acute ischemic stroke, in Guangzhou.
Method: A total of 98 patients with acute ischemic stroke were assessed with the Cantonese version of the BCoS, and an additional 133 healthy individuals were recruited as controls. Apart from the BCoS, the patients also completed a number of external cognitive tests, including the Montreal Cognitive Assessment Test (MoCA), Mini Mental State Examination (MMSE), Albert's cancellation test, the Rey-Osterrieth Complex Figure Test, and six gesture matching tasks. Cutoff scores for failing each subtest, ie, deficits, were computed based on the performance of the controls. The validity and reliability of the Cantonese BCoS were examined, as well as interrater and test-retest reliability. We also compared the proportions of cases being classified as deficits in controlled attention, memory, character writing, and praxis, between patients with and without spoken language impairment.
Results: Analyses showed high test-retest reliability and agreement across independent raters on the qualitative aspects of measurement. Significant correlations were observed between the subtests of the Cantonese BCoS and the other external cognitive tests, providing evidence for convergent validity of the Cantonese BCoS. The screen was also able to generate measures of cognitive functions that were relatively uncontaminated by the presence of aphasia.
Conclusion: This study suggests good reliability and validity of the Cantonese version of the BCoS. The Cantonese BCoS is a very promising tool for the detection of cognitive problems in Cantonese speakers.
Keywords: Cantonese speakers; cerebral infarction; cognitive impairment; neuropsychological testing; reliability test; validation test.
Similar articles
-
Preliminary validation study of the Russian Birmingham Cognitive Screen.J Clin Exp Neuropsychol. 2018 Feb;40(1):1-16. doi: 10.1080/13803395.2017.1301884. Epub 2017 Mar 14. J Clin Exp Neuropsychol. 2018. PMID: 28290234
-
The BCoS cognitive profile screen: Utility and predictive value for stroke.Neuropsychology. 2015 Jul;29(4):638-48. doi: 10.1037/neu0000160. Epub 2014 Dec 29. Neuropsychology. 2015. PMID: 25545235
-
The Hong Kong version of the Oxford Cognitive Screen (HK-OCS): validation study for Cantonese-speaking chronic stroke survivors.Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016 Sep;23(5):530-48. doi: 10.1080/13825585.2015.1127321. Epub 2015 Dec 24. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2016. PMID: 26702642
-
Validity of the Cantonese Chinese Montreal Cognitive Assessment in Southern Chinese.Geriatr Gerontol Int. 2015 Jan;15(1):96-103. doi: 10.1111/ggi.12237. Epub 2014 Jan 24. Geriatr Gerontol Int. 2015. PMID: 24456109
-
On the importance of cognitive profiling: A graphical modelling analysis of domain-specific and domain-general deficits after stroke.Cortex. 2015 Oct;71:190-204. doi: 10.1016/j.cortex.2015.06.006. Epub 2015 Jun 23. Cortex. 2015. PMID: 26232552
Cited by
-
Psychometric properties of cognitive screening for patients with cerebrovascular diseases A systematic review.Dement Neuropsychol. 2019 Jan-Mar;13(1):31-43. doi: 10.1590/1980-57642018dn13-010004. Dement Neuropsychol. 2019. PMID: 31073378 Free PMC article.
-
Quality of Assessment Tools for Aphasia: A Systematic Review.Brain Sci. 2025 Mar 3;15(3):271. doi: 10.3390/brainsci15030271. Brain Sci. 2025. PMID: 40149792 Free PMC article. Review.
References
-
- Rasquin SM, Lodder J, Visser PJ, Lousberg R, Verhey FR. Predictive accuracy of MCI subtypes for Alzheimer’s disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study. Dement Geriatr Cogn Disord. 2005;19(2–3):113–119. - PubMed
-
- Alvarez-Sabín J, Román GC. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke. 2011;42(1 Suppl):S40–S43. - PubMed
-
- Erkinjuntti T, Román G, Gauthier S, Feldman H, Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke. 2004;35(4):1010–1017. - PubMed
LinkOut - more resources
Full Text Sources